Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
2022 · Hepatology International · 30 citations
https://doi.org/10.1007/s12072-022-10396-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
175
Papers
1.2K
Citations
19
h-index
43
i10-index
Ruijun Zhang is an academic researcher. The author has contributed to research in topics: Vibration and Dynamic Analysis & Elevator Systems and Control & Aerodynamics and Fluid Dynamics Research. The author has an h-index of 19, co-authored 149 publications.
ORCID: 0000-0002-0559-056Xhttps://doi.org/10.1007/s12072-022-10396-7
https://doi.org/10.1038/s41467-024-53662-y
https://doi.org/10.1016/j.tws.2024.112014
https://doi.org/10.1088/1742-6596/2820/1/012058
Click to start Chat